Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

How to Get Turalio (Pexidartinib) Covered by Blue Cross Blue Shield in Michigan: Complete PA Timeline & Appeal Guide

Answer Box: Getting Turalio Covered by Blue Cross Blue Shield in Michigan Blue Cross Blue Shield of Michigan requires prior authorization for Turalio (pexidartinib) to treat TGCT, with approval contingent on REMS enrollment, confirmed diagnosis, and surgical non-feasibility documentation. The fastest path: (1) Enroll all parties in REMS at turaliorems.

How to Get Synagis (Palivizumab) Covered by Blue Cross Blue Shield in North Carolina: Complete PA Guide and Appeals Process

Answer Box: Getting Synagis Covered by Blue Cross Blue Shield in North Carolina Synagis (palivizumab) requires prior authorization from Blue Cross Blue Shield of North Carolina for high-risk infants during RSV season (September-March). Submit the RSV Prophylaxis fax form with NICU records, cardiology/pulmonology consults, and gestational age documentation. If

How to Get Pemazyre (pemigatinib) Covered by Blue Cross Blue Shield in New Jersey: Prior Authorization Guide & Appeal Process

Quick Answer: Getting Pemazyre Covered in New Jersey Pemazyre (pemigatinib) requires prior authorization from Blue Cross Blue Shield in New Jersey for cholangiocarcinoma with FGFR2 fusion or myeloid/lymphoid neoplasms with FGFR1 rearrangement. Submit PA with FGFR testing results, oncologist attestation, and prior therapy documentation. If denied, file internal appeals

How to Get Humate-P Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Horizon Blue Cross Blue Shield of New Jersey requires prior authorization for Humate-P through their Medical Injectables Program. Submit via provider portal with hematologist documentation, VWF labs, and desmopressin trial results (if applicable). If denied, use New Jersey's IHCAP external review program managed by Maximus Federal

How Long Does It Take to Get Abecma (idecabtagene vicleucel) Approved by Blue Cross Blue Shield in Washington? Complete Timeline & Appeals Guide

Answer Box: Fastest Path to Abecma Approval Blue Cross Blue Shield plans in Washington (Premera, Regence) typically process Abecma prior authorization in 1-5 business days for standard requests, 72 hours for urgent cases. Submit complete documentation including ≥2 prior therapy failures (IMiD, proteasome inhibitor, anti-CD38), recent labs, and treatment at

How to Get Thiola / Thiola EC (tiopronin) Covered by Blue Cross Blue Shield Virginia: Timeline, Appeals & Documentation

Answer Box: Getting Thiola Covered by Blue Cross Blue Shield Virginia Blue Cross Blue Shield Virginia (Anthem) requires prior authorization for Thiola/Thiola EC (tiopronin) to treat cystinuria. The fastest path to approval involves submitting complete documentation including 24-hour urine cystine levels >500 mg/day, documented failure of alkalinization

How to Get Revlimid (Lenalidomide) Covered by Blue Cross Blue Shield Michigan: Complete Prior Authorization and Appeals Guide 2025

Answer Box: Getting Revlimid Covered by BCBS Michigan Blue Cross Blue Shield of Michigan requires prior authorization for Revlimid (lenalidomide) through their Oncology Value Management program. The fastest path to approval involves three key steps: (1) Ensure REMS compliance documentation is complete, (2) Submit PA request via OncoHealth with complete

How to Get Cystadane (betaine anhydrous) Covered by Blue Cross Blue Shield of Texas: Prior Authorization, Appeals, and State Protections

Answer Box: Getting Cystadane Covered in Texas Blue Cross Blue Shield of Texas requires prior authorization for Cystadane (betaine anhydrous) for homocystinuria. Submit through Carelon Medical Benefits Management at 1-866-455-8415 or via Availity with diagnosis confirmation, lab results showing elevated homocysteine (>50 µmol/L), and documentation of vitamin therapy

Getting Defitelio (Defibrotide) Covered by Blue Cross Blue Shield in New York: PA Requirements, Appeals, and Cost Assistance

Answer Box: Getting Defitelio Covered by Blue Cross Blue Shield in New York Defitelio (defibrotide) requires prior authorization from Blue Cross Blue Shield plans in New York for hepatic veno-occlusive disease (VOD) with organ dysfunction post-HSCT. Your fastest path: (1) Have your transplant team submit PA with VOD diagnosis documentation

Get Humira (Adalimumab) Approved by Blue Cross Blue Shield North Carolina: Complete Forms, Appeals & Contact Guide

Answer Box: Getting Humira Approved by BCBS North Carolina Blue Cross Blue Shield of North Carolina requires prior authorization for Humira (adalimumab) with step therapy through preferred biosimilars first. Submit PA via the Availity Provider Portal or call 800-672-7897. Include clinical documentation of biosimilar failures, diagnosis codes, and medical necessity.